FDA Approved: RIVASTIGMINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for rivastigmine from Mylan Pharmaceuticals Inc. under ANDA 205622, updating the generic product's approval. Rivastigmin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE (RIVASTIGMINE)